CD68 and Cirrhosis: Although CD68+ macrophages did not differ significantly across different stages of cirrhosis, the number of AXL-expressing CD68+ resident liver macrophages per high-power field (HPF) was significantly reduced in advanced stages of cirrhosis, as was the percentage of AXL+ cells relative to the CD68+ macrophage population (Figure 2B).